$CVKD
Cadrenal Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$1.05
▲+8.28%+$0.080
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateCadrenal Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is CVKD up today? It is at $1.05 (+8.28%), and our scanner flagged it 16 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CVKD spikes, and full due diligence on CVKD — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $CVKD 16 times in the last 30 days. Create a free account to track $CVKD, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on CVKD from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Likely catalysthas reached clinical and regulatory maturity following recent alignment with FDA on Phase, from an SEC filing. Read it →Latest filing4Ownership documentOct 14, 2026 · 3 days agoAcross every filing on file, supply equal to at least 207.3% of the tradeable float is in play - 207.3% more can still be issued.
Some filings did not state a size, so these are floors.
One filing exceeds the whole float, which usually means our share count is stale. Check the filing directly.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
5,822,400 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $3.0M in size
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Pham Quang X Officer | Sold (automatic/other) | -7K 0.2% of company | sold 7.0% | 99K | $22K at $3.03 | Jun 29, 26 |
Pham Quang X Officer | Sold (automatic/other) | -9K 0.3% of company | sold 7.9% | 106K | $28K at $3.05 | Jun 26, 26 |
Pham Quang X Officer | Sold (automatic/other) | -2K 0.06% of company | sold 1.8% | 115K | $6K at $3.00 | Jun 25, 26 |
Pham Quang X Officer | Sold (automatic/other) | -2K 0.06% of company | sold 1.9% | 117K | $7K at $3.20 | Jun 23, 26 |
Pham Quang X Officer | Sold (automatic/other) | -9K 0.3% of company | sold 7.1% | 119K | $33K at $3.55 | Jun 22, 26 |
Pham Quang X Officer | Sold (automatic/other) | -513 0.01% of company | sold 0.4% | 129K | $2K at $3.16 | Jun 17, 26 |
Pham Quang X Officer | Sold (automatic/other) | -4K 0.1% of company | sold 2.7% | 129K | $11K at $3.18 | Jun 16, 26 |
Pham Quang X Officer | Sold (automatic/other) | -4K 0.1% of company | sold 2.7% | 133K | $13K at $3.58 | Jun 15, 26 |
Pham Quang X Officer | Sold (automatic/other) | -13K 0.4% of company | sold 8.7% | 136K | $51K at $3.94 | Jun 12, 26 |
Pham Quang X Officer | Sold (automatic/other) | -1K 0.04% of company | sold 1.0% | 149K | $6K at $4.12 | Jun 11, 26 |
Pham Quang X Officer | Sold (automatic/other) | -4K 0.10% of company | sold 2.3% | 151K | $15K at $4.21 | Jun 10, 26 |
Pham Quang X Officer | Sold (automatic/other) | -13K 0.4% of company | sold 7.8% | 154K | $53K at $4.06 | Jun 9, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on CVKD from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
CVKD last traded at $1.05, up 8.28% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Cadrenal Therapeutics, Inc. Common Stock (CVKD) is next expected to report earnings on Monday, November 9, 2026, about 24 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The CVKD Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CVKD 16 times in the last 30 days.
CVKD (Cadrenal Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $4M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CVKD for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$CVKD discussion
Sign in to ask a question or join the discussion.